BCG Vaccines Market to Grow with a CAGR of 5.90% through 2030F
Government immunization programs and Drug-resistant TB are factors driving the global BCG Vaccines market in the forecast period 2026-2030
According
to TechSci Research report, “BCG Vaccines Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global BCG Vaccines Market stood at USD 145.56 million in 2024 and is
anticipated to grow with a CAGR of 5.90% in the forecast period, 2025-2030. The
COVID-19 pandemic had a substantial impact on the BCG vaccine market initially.
The strict lockdowns and government regulations intended to slow down the
spread of COVID-19 resulted in a decrease in demand for the BCG vaccine due to
the lack of visits to healthcare facilities such as hospitals and clinics. The
outbreak of the pandemic also resulted in a shortage of support staff for
pediatric vaccination, which includes BCG vaccination as well. The vaccine
manufacturing companies prioritized manufacturing COVID-19 vaccines instead of
other vaccines, which in turn created a shortage of BCG vaccines as well.
For
instance, a modeling study was conducted to evaluate the impact of COVID-19 on
global BCG vaccine coverage and was published in October 2021 in the journal of
the National Center for Biotechnology Information (NCBI). The results of the
study showed that there was substantial variation in the impact of COVID-19 on
routine BCG vaccination programs; some African countries showed average BCG
coverage, while others showed lower rates from January to June 2020. It also
found that there was a 50 percent decline in BCG coverage in India during the
pandemic period. As per an article titled "Impact of COVID-19 on routine
immunization in South-East Asia and Western Pacific: Disruptions and
Solutions," published in the journal The Lancet in April 2021, fear of
infection, restriction of movement, and limited access to healthcare were the
main reasons for COVID-related disruption to immunization services which
includes BCG vaccination as well. Thus, the COVID-19 outbreak affected the
market's growth adversely in its preliminary phase; however, the market is expected
to gain traction due to the significant increase in the use of BCG vaccines
globally.
Further, the rising prevalence of tuberculosis, technological advancement in vaccine research and development, and rise in government initiatives for vaccination programs are among the significant factors driving the studied market growth. Poverty, homelessness, and HIV infections are the main causes of tuberculosis, and the BCG vaccine is the only vaccine that prevents
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global BCG Vaccines Market”
The
Global BCG Vaccines Market is segmented into product, application, distribution
channel and company.
Based
on product, Therapy BCG is the fastest-growing segment in the global BCG
vaccines market, driven by its expanding use in bladder cancer treatment and
rising incidence of non-muscle invasive bladder cancer (NMIBC). Unlike immune
BCG, primarily used for tuberculosis prevention, therapy BCG is a
well-established immunotherapy for bladder cancer, stimulating the immune
system to attack cancer cells. The increasing approval of novel BCG
formulations, supply chain improvements, and heightened research in oncology
further accelerate its growth. The growing geriatric population, which is more
susceptible to bladder cancer, boosts demand, making therapy BCG a key driver
of market expansion.
Based
on region, Asia Pacific is the fastest-growing region for BCG (Bacillus
Calmette-Guérin) vaccines due to several key factors. First, this region hosts
a substantial portion of the world's population, with several countries
experiencing high tuberculosis (TB) burden. The need for TB prevention is
paramount, driving increased demand for BCG vaccines. Second, rapid
urbanization and population density in many Asian countries create environments
conducive to TB transmission, heightening the urgency for vaccination. Third,
robust government immunization programs, expanding healthcare infrastructure,
and rising awareness of TB's impact contribute to the market's growth. The
emergence of drug-resistant TB strains in some Asian nations underscores the
importance of vaccination as a preventive measure. Altogether, these factors
position Asia Pacific as the fastest-growing market for BCG vaccines,
addressing TB's significant public health challenge in the region.
Major
companies operating in Global BCG Vaccines Market are:
- Serum
Institute of India Pvt. Ltd.
- GreenSignal
Bio Pharma Ltd
- Taj
Pharmaceuticals Limited
- Japan
BCG Laboratory
- Merck
& Co., Inc.
- Microgen
LLC
- Biomed
Lublin S.A.
- BCG
Vaccine Laboratory
- China
Biotechnology Co., Ltd.
- AJ
Biologics Sdn Bhd
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“The
future of BCG (Bacillus Calmette-Guérin) vaccines is promising and
multifaceted. Ongoing research aims to enhance BCG vaccine formulations, making
them more effective against emerging strains of tuberculosis (TB) and exploring
their potential applications in broader immunology. With the threat of
drug-resistant TB on the rise, BCG vaccines will continue to play a critical
role in TB prevention. Their potential role in bolstering overall immunity, as
seen during the COVID-19 pandemic, may lead to expanded applications. As global
health security concerns persist, BCG vaccines will remain pivotal in pandemic
preparedness. Ensuring equitable access to vaccines will be essential to reduce
TB incidence and improve public health worldwide”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“BCG Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Immune BCG, Therapy BCG), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), By Region & Competition 2020-2030F”, has evaluated the future growth potential of Global BCG
Vaccines Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global BCG Vaccines Market.
Contact
TechSci
Research LLC
420
Lexington Avenue,
Suite
300, New York,
United
States- 10170
M:
+13322586602
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com